In this entry Bruce Maches takes a high-level look at SaaS and how it can be leveraged by these organizations to help them meet their research objectives in a more cost effective and timely manner.
This week at Pharmtech, Arun Kumar, Vice President and Head of the Global Life Sciences Business Unit at Infosys, an IT, business and consulting firm, discussed how the cloud is shaping the pharmaceutical industry–and what is coming in 2011.
In terms of enterprise HPC cloud adoption, the pharmaceutical industry is a relative leader due to its need to reduce time to market via the on-demand, scalable access to resources on a pay-as-you-go basis. The computational strategies are well-suited to cloud in other ways as well, as CloudSwitch founder Ellen Rubin explains.
Most big pharma IT departments have extensive application portfolios that range into the hundreds of systems. Many of these have overlapping functionality and use a variety of different platforms and technologies. This tower of Babel is caused by a number of different factors